Development of a Cell-Based Reporter Assay for Measuring ADAR1 Editing Activity for Drug Discovery and Cell Biology Research

May 21st, 2024 • 8 a.m. PT, 11 a.m. ET

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

Adenosine Deaminase Acting on RNA (ADAR) enzymes perform adenosine to inosine base editing in RNA, particularly targeting adenosines located within a specific double-stranded stem-loop motif.  ADAR1 plays important roles in inflammation, autoimmune diseases, and cancer, and represents an attractive target for therapeutic development.

BPS Bioscience has developed and validated high-throughput, cell-based assays for measuring ADAR1 editing activity.  This webinar will describe the principle of these cell-based assays, present data, and discuss the scientific applications of the cell lines.

You will learn about:

  • The function of ADAR1
  • How ADAR1 RNA-editing activity can be measured using a luciferase reporter system
  • The research applications of ADAR1 reporter cell-based assays
Who should attend:
  • Drug discovery & development scientists
  • Cell biologists
  • RNA editing researchers
  • Gene therapy researchers

Presenters

Presenter
Valerie Sapp, PhD
Research Scientist II,
BPS Bioscience
View Biography
Presenter
Veronique Baron, PhD, HDR
Associate Director Scientific Applications,
BPS Bioscience
View Biography
Presenter
Tamlyn Oliver
(Moderator)
Managing Editor
Biocompare
View Biography